These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33562775)

  • 1. Fecal Immunochemical Tests Detect Screening Participants with Multiple Advanced Adenomas Better than T1 Colorectal Cancers.
    Gies A; Niedermaier T; Gruner LF; Heisser T; Schrotz-King P; Brenner H
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33562775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity of Fecal Immunochemical Test for Colorectal Cancer Detection Differs According to Stage and Location.
    Niedermaier T; Tikk K; Gies A; Bieck S; Brenner H
    Clin Gastroenterol Hepatol; 2020 Dec; 18(13):2920-2928.e6. PubMed ID: 31988043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for colon cancer: A test for occult blood.
    Khakimov N; Khasanova G; Ershova K; Gibadullina L; Vetkina T; Lobisheva G; Chumakova A
    Int J Risk Saf Med; 2015; 27 Suppl 1():S110-1. PubMed ID: 26639687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stage-Specific Sensitivity of Fecal Immunochemical Tests for Detecting Colorectal Cancer: Systematic Review and Meta-Analysis.
    Niedermaier T; Balavarca Y; Brenner H
    Am J Gastroenterol; 2020 Jan; 115(1):56-69. PubMed ID: 31850933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
    van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
    Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of nine faecal immunochemical tests for the detection of colorectal cancer.
    Tao S; Seiler CM; Ronellenfitsch U; Brenner H
    Acta Oncol; 2013 Nov; 52(8):1667-75. PubMed ID: 23617541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of Different Fecal Immunochemical Tests in Colorectal Cancer Screening: Any Gain in Diagnostic Performance?
    Gies A; Cuk K; Schrotz-King P; Brenner H
    Cancers (Basel); 2019 Jan; 11(1):. PubMed ID: 30669538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic performance of quantitative fecal immunochemical test in detection of advanced colorectal neoplasia].
    Lu M; Chen HD; Liu CC; Zhang YH; Wei LP; Lyu ZY; Ren JS; Shi JF; Zou SM; Li N; Dai M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Dec; 41(12):2104-2111. PubMed ID: 33378824
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical performance of an automated stool DNA assay for detection of colorectal neoplasia.
    Lidgard GP; Domanico MJ; Bruinsma JJ; Light J; Gagrat ZD; Oldham-Haltom RL; Fourrier KD; Allawi H; Yab TC; Taylor WR; Simonson JA; Devens M; Heigh RI; Ahlquist DA; Berger BM
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1313-8. PubMed ID: 23639600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative immunochemical fecal occult blood test for neoplasia in colon cancer screening.
    Yuan SY; Wu W; Fu J; Lang YX; Li JC; Guo Y; Wang YN; Qian JM; Li JN
    J Dig Dis; 2019 Feb; 20(2):78-82. PubMed ID: 30714346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct Comparison of Diagnostic Performance of 9 Quantitative Fecal Immunochemical Tests for Colorectal Cancer Screening.
    Gies A; Cuk K; Schrotz-King P; Brenner H
    Gastroenterology; 2018 Jan; 154(1):93-104. PubMed ID: 28958859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal immunochemical test for hemoglobin in combination with fecal transferrin in colorectal cancer screening.
    Gies A; Cuk K; Schrotz-King P; Brenner H
    United European Gastroenterol J; 2018 Oct; 6(8):1223-1231. PubMed ID: 30288285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Imperfect Compliance With Instructions for Fecal Sample Collection on Diagnostic Performance of 9 Fecal Immunochemical Tests.
    Gies A; Gruner LF; Schrotz-King P; Brenner H
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1829-1839.e4. PubMed ID: 30851476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single immunochemical fecal occult blood test for detection of colorectal neoplasia.
    Sohn DK; Jeong SY; Choi HS; Lim SB; Huh JM; Kim DH; Kim DY; Kim YH; Chang HJ; Jung KH; Ahn JB; Kim HK; Park JG
    Cancer Res Treat; 2005 Feb; 37(1):20-3. PubMed ID: 19956505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electronic nose can discriminate colorectal carcinoma and advanced adenomas by fecal volatile biomarker analysis: proof of principle study.
    de Meij TG; Larbi IB; van der Schee MP; Lentferink YE; Paff T; Terhaar Sive Droste JS; Mulder CJ; van Bodegraven AA; de Boer NK
    Int J Cancer; 2014 Mar; 134(5):1132-8. PubMed ID: 23959518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equivalent Accuracy of 2 Quantitative Fecal Immunochemical Tests in Detecting Advanced Neoplasia in an Organized Colorectal Cancer Screening Program.
    Wieten E; de Klerk CM; van der Steen A; Ramakers CR; Kuipers EJ; Hansen BE; Lansdorp-Vogelaar I; Bossuyt PM; Dekker E; Spaander MCW
    Gastroenterology; 2018 Nov; 155(5):1392-1399.e5. PubMed ID: 30055170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal occult blood versus DNA testing: indirect comparison in a colorectal cancer screening population.
    Brenner H; Chen H
    Clin Epidemiol; 2017; 9():377-384. PubMed ID: 28761377
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.